Objective We aimed to estimate prevalence and identify determinants of hypertension in adults aged 15–49 years in Tanzania.

Introduction Objective and accurate dietary monitoring is critical for comprehensive dietary assessment and improving ...

Objective To explore the association between biological rhythm and internalising disorders among children and adolescents. Design, setting and participants This cross-sectional study used data from ...

Background Stillbirths and associated outcomes remain a significant concern in sub-Saharan Africa (SSA), with approximately 41% of global stillbirths. Design Our cross-sectional analysis included a ...

Objectives This study aimed to explore the relationship between oral health and the knowledge, attitudes and practices (KAP) of parents and teachers of kindergarten students towards oral health.

Background The KEYNOTE-966 study demonstrated that pembrolizumab combined with chemotherapy is more effective than chemotherapy alone as first-line treatment for patients with advanced biliary tract ...

Objectives This study aimed to assess the association between longitudinal change in non-high-density lipoprotein cholesterol (non-HDL-C) and subsequent cardiovascular disease (CVD) risk. Design A ...

Introduction Non-pharmacological interventions, including musculoskeletal manipulations (MMs), have been proven effective for musculoskeletal disorders. Objectives To evaluate if MMs, including ...

Design A Monte Carlo simulation modelling approach was employed. Input parameters included adult population estimates and mortality rates; autism population all-cause mortality risk ratios; and autism ...

Objectives During the COVID-19 pandemic, addiction treatment services received official guidance asking them to limit face-to-face contact with patients and to prescribe opioid agonist treatment (OAT) ...

Objectives This study aims to evaluate the prevalence of nutritional anaemia and identify its associated factors among pregnant women in the Sibu Sire District, Western Ethiopia. Design A ...

Objectives Penpulimab is a novel programmed death-1 (PD-1) inhibitor that has been approved in China for use in combination with chemotherapy as a first-line treatment for locally advanced or ...